Professor, Pediatrics, UCSD School of Medicine

Pediatric Gastroenterology

Ranjan Dohil works in the field of Pediatric Gastroenterology. Ranjan Dohil is also published. He has 44 publications published. The lastest publication: "Treatment of orofacial and ileo-colonic Crohn''s disease with total enteral nutrition.'

Publications

---

• Rigid substrate induces esophageal smooth muscle hypertrophy and eosinophilic esophagitis fibrotic gene expression.
• Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
• Group 2 innate lymphocytes (ILC2s) are enriched in active eosinophilic esophagitis.
• TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.
• Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.
• Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
• Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery.
• The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic Fatty liver disease and healthy subjects.
• A potential new method to estimate tissue cystine content in nephropathic cystinosis.
• Oral viscous budesonide therapy in children with epidermolysis bullosa and proximal esophageal strictures.
• Eosinophilic esophagitis: Updated consensus recommendations for children and adults.
• Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease.
• Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction.
• Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study.
• Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
• Chronic constipation, atypical eating pattern, weight loss, and anxiety in a 19-year old youth.
• Long-term treatment of cystinosis in children with twice-daily cysteamine.
• A symptom scoring tool for identifying pediatric patients with eosinophilic esophagitis and correlating symptoms with inflammation.
• Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease.
• Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids.
• Twice-daily cysteamine bitartrate therapy for children with cystinosis.
• Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis.
• Intravenous delivery of cysteamine for the treatment of cystinosis: association with hepatotoxicity.
• Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
• Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder.
• Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion.
• Esophageal remodeling in pediatric eosinophilic esophagitis.
• Understanding intestinal cysteamine bitartrate absorption.
• Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol.
• Topical viscous budesonide suspension for treatment of eosinophilic esophagitis.
• Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis.
• First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.
• Esophagogastric disconnection following failed fundoplication for the treatment of gastroesophageal reflux disease (GERD) in children with severe neurological impairment.
• Granular cell tumor of the esophagus: report of a pediatric case and literature review.
• The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine.
• Peptic ulcer disease in children.
• Gastritis and gastropathy of childhood.
• Spectrum of gastritis in celiac disease in childhood.
• Treatment of orofacial and ileo-colonic Crohn''s disease with total enteral nutrition.
• Esophageal stenosis in children.
• Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease.
• Effective 2-wk therapy for Helicobacter pylori disease in children.
• Constipation and reversible urinary tract abnormalities.

Schools

---

• University Of Wales School Of Medicine

Doctors Specialties

---

• Pediatrics
• Pediatric Gastroenterology

Accepted Insurances

---

Hospital

---

• Rady Children's Hospital - San Diego

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Yoko T. Udaka, MD
	Dr. Trevor H. Henderson, MD This Doctor is OpenDoctor Recommended.
	Dr. Michelle L. Leff, MD
	Dr. Robert S. Zeiger, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Hannah I. Awai, MD This Doctor is OpenDoctor Recommended.
	Dr. Mackenzie E. Coffin, MD
	Dr. Rebecca N. Cherry, MD This Doctor is OpenDoctor Recommended.
	Dr. Tamara N. Taketani, MD This Doctor is OpenDoctor Recommended.
	Dr. Sherry C. Huang, MD This Doctor is OpenDoctor Recommended.
	Dr. Eitan Rubinstein, MD
	Dr. Thomas W. Self, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles C. Yang, MD
	Dr. Jeannie S. Huang, MD This Doctor is OpenDoctor Recommended.
	Dr. Warren L. Shapiro, MD This Doctor is OpenDoctor Recommended.
	Dr. Sharon F. Taylor, MD This Doctor is OpenDoctor Recommended.
	Dr. Daphne S. Say, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog